Information for "Predictive implications regarding reduced CA199 with 8weeks through nabpaclitaxel in addition gemcitabine to the induction regarding secondline radiation treatment for patients with sophisticated pancreatic cancer malignancy"
From EECH Central
Basic information
| Display title | Predictive implications regarding reduced CA199 with 8weeks through nabpaclitaxel in addition gemcitabine to the induction regarding secondline radiation treatment for patients with sophisticated pancreatic cancer malignancy |
| Default sort key | Predictive implications regarding reduced CA199 with 8weeks through nabpaclitaxel in addition gemcitabine to the induction regarding secondline radiation treatment for patients with sophisticated pancreatic cancer malignancy |
| Page length (in bytes) | 3,429 |
| Page ID | 1325998 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Purpledrop3 (Talk | contribs) |
| Date of page creation | 09:44, 1 April 2024 |
| Latest editor | Purpledrop3 (Talk | contribs) |
| Date of latest edit | 09:44, 1 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
